Possibilities of transient and two-dimensional shear wave elastography in the diagnosis of fibrosis in chronic diffuse liver diseases of non-viral etiology

Author:

Zhirkov I. I.1ORCID,Gordienko A. V.1ORCID,Pavlovich I. M.1ORCID,Yakovlev V. V.1ORCID,Serdyukov D. Yu.1ORCID

Affiliation:

1. The Military Medical Academy name after S.M. Kirov

Abstract

The aim of the research: to study the possibilities of transient and two-dimensional shear wave elastography in the diagnosis of fibrosis in chronic diffuse liver diseases of non-viral etiologyMaterials and methods: the study included 415 male patients aged 19 to 54 years (average age 40.4 ± 7.8 years), including 156 with non-alcoholic fatty liver disease, 66 with alcoholic liver disease, 122 with fatty disease liver alcohol-metabolic etiology, 68 people without liver disease. The examination plan included the measurement of anthropometric indicators, a biochemical study of blood serum, an ultrasound study of the hepatobiliary zone, a morphological study of liver tissue, transient and two-dimensional shear wave elastography.Results: according to the results of transient and two-dimensional shear wave elastography, the degree of fibrotic changes with combined alcohol-metabolic liver disease is higher than with isolated exposure to an alcoholic or metabolic factor; the highest diagnostic significance in elastographic research methods was noted in the third and fourth stages of fibrosis, in the second stage, the quality of the diagnostic model in transient elastography was higher than in two-dimensional shear wave.

Publisher

LLC Global Media Technology

Subject

General Medicine

Reference14 articles.

1. Balukova E. V., Uspenskiy Yu.P., Fominykh Yu. A. Liver diseases of various genesis (toxic, drug-induced, dys-metabolic): from etiological heterogenicity to a single unified therapy of patients. RMJ. Medical Review. 2018. no. 1(I), pp. 35-40.

2. Hagstrom, Н. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. Journal of hepatology. 2017. Vol. 67, no. 6, pp. 1265-1273.

3. Long Wang, Jinghui Guo, Jianping Lu. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget. 2016. Vol. 7, no. 24, pp. 35632-35642.

4. Bedogni, G. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006. no. 6, pp. 33.

5. Bedossa P. FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease / P. Bedossa. Hepatology. 2014. Vol. 60, pp. 565-575.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Diagnosis of liver fibrosis: an emphasis on elastography;Experimental and Clinical Gastroenterology;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3